The effects of recombinant tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) on B16 mouse melanoma experimental metastatic ability and major histocompatibility complex (H-2b) antigens expression were studied. B16 cells exposed in vitro to TNF-alpha had an increased H-2 expression and were more metastatic than untreated cells. The simultaneous treatment with TNF-alpha and IFN-gamma amplified the enhancement of experimental metastasis and all other effects obtained with TNF-alpha alone. The B16 clone B78H1, selectively resistant to H-2 induction and to enhancement of metastatic ability by IFN-gamma, was not affected by treatment with TNF-alpha and with TNF-alpha + IFN-gamma. These findings contribute to a better understanding of the pleiotropic effects of TNF, some of which can have opposing actions in the complex tumor-host relationships.[/p]
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Eisenbach, L., Hollander, N., Greenfeld, L., Yakor, H., Segal, S., and Feldman, M., 1984, The differential expression of H-2K versus H-2D antigens distinguishing high-metastatic from low-metastatic clones is correlated with the immunogenic properties of the tumor cells. International Journal of Cancer, 34, 567–573.
Eisenbach, L., Segal, S., and Feldman, M., 1983, MHC imbalance and metastatic spread in Lewis lung carcinoma clones. International Journal of Cancer, 32, 113–120.
Gopas, J., Segal, S., Hammerling, G., Bar-Eli, M., and Rager-Zisman, B., 1988, Influence of H-2K transfection on susceptibility of fibrosarcoma tumor cells to natural killer (NK) cells. Immunology Letters, 17, 261–266.
Graf, L. H., Kaplan, P., and Silagi, S., 1984, Efficient DNA-mediated transfer of selectable genes and unselected sequences into differentiated and undifferentiated mouse melanoma clones. Somatic Cell and Molecular Genetics, 10, 139–151.
Hanna, N., and Burton, R. C., 1981, Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastasis in vivo. Journal of Immunology, 127, 1754–1758.
Kawano, Y.-I., Taniguchi, K., Toshitani, A., and Nomoto, K., 1986, Synergistic defense system by cooperative natural effectors against metastasis of B16 melanoma cells in H-2-associated control: different behavior of H-2+ and H-2− cells in metastatic processes. Journal of Immunology, 136, 4729–4734.
Lollini, P.-L., De Giovanni, C., Del Re, B., Nicoletti, G., Prodi, G., and Nanni, P., 1987, Interferon-mediated enhancement of metastasis. Are MHC antigens involved? Clinical and Experimental Metastasis, 5, 277–287.
Lollini, P.-L., De Giovanni, C., Del Re, B., Nicoletti, G., Prodi, G., Scotlandi, K., and Nanni, P., 1988, Interferon-mediated modulation of metastasis and MHC antigens. Cancer Metastasis—Biological and biochemical mechanisms and clinical aspects, edited by G.Prodi, L. A. Liotta, P.-L. Lollini, S. Garbisa, S. Gorini, and K. Hellmann (New York: Plenum Press), pp. 129–140.
McMillan, T.J., Rao, J., Everett, C. A., and Hart, I. R., 1987, Interferon-induced alterations in metastatic capacity, class- I antigen expression and natural killer sensitivity of melanoma cells. International Journal of Cancer, 40, 659–663.
Nanni, P., Colombo, M. P., De Giovanni, C., Lollini, P.-L., Nicoletti, G., Parmiani, G., and Prodi, G., 1983, Impaired H-2 expression in B16 melanoma variants. Journal of Immunogenetics, 10, 361–370.
Pfizenmaier, K., Scheurich, P., Schlueter, C., and Kroenke, M., 1987, Tumor necrosis factor enhances HLA-A, B, C and HLA-DR gene expression in human tumor cells. Journal of Immunology, 138, 975–980.
Rager-Zisman, B., Gopas, J., Bar-Eli, M., Har-Vardi, I., Hammerling, G. J., and Segal, S., 1988, NK sensitivity, H-2, c-K-ras proto-oncogene expression and metastases: analysis of the metastatic potential of H-2 gene transfected fibrosarcoma cells. Cancer Metastasis—Biological and biochemical mechanisms and clinical aspects, edited by G. Prodi, L. A. Liotta, P.-L. Lollini, S. Garbisa, S. Gorini, and K. Hellmann (New York: Plenum Press), pp. 151–160.
Ramani, P., and Balkwill, F. R., 1987, Enhanced metastasis of a mouse carcinoma after in vitro treatment with murine interferon-gamma. International Journal of Cancer, 40, 830–834.
Sugarman, R. J., Aggarwal, B. B., Hass, P. E., Figari, I. S., Palladino, M. A. J., and Shepard, H. M., 1985, Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science, 230, 943–945.
Talmadge, J. E., Tribble, H. R., Pennington, R. W., Phillips, H., and Wiltrout, R. H., 1987, Immunomodulatory and immuno therapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice. Cancer Research, 47, 2563–2570.
Taniguchi, K., Karre, K., and Klein, G., 1985, Lung colonization and metastasis by disseminated B16 melanoma cells. H-2 associated control at the level of the host and the tumor cell. International Journal of Cancer, 36, 503–510.
Taniguchi, K., Petersson, M., Hoglund, P., Kiessling, R., Klein, G., and Karre, K., 1987, Interferon-gamma induces lung colonization by intravenously inoculated B16 melanoma cells in parallel with enhanced expression of class I major histocompatibility complex antigens. Proceedings of the National Academy of Sciences, U.S.A., 84, 3405–3409.
Wexler, H., 1966, Accurate identification of experimental pulmonary metastases. Journal of the National Cancer Institute, 36, 641–645.
Wiltrout, R. H., Herberman, R. B., Zhang, S.-R., Chirigos, M. A., Ortaldo, J. R., Green, K. M. Jr, and Talmadge, J. E., 1985, Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. Journal of Immunology, 134, 4267–4275.
Wong, G. H. W., and Goeddel, D. V., 1986, Tumor necrosis factors alpha and beta inhibit virus replication and synergise with interferons. Nature, 323, 819–822.
Zoeller, M., Strubel, A., Haemmerling, G., Andrighetto, G., Raz, A., and Benze'ev, A., 1988, Interferon-gamma treatment of B16 melanoma cells: opposing effects for non-adaptive and adaptive immune defense and its reflection by metastatic spread. International Journal of Cancer, 41, 256–266.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lollini, P.L., De Giovanni, C., Nicoletti, G. et al. Enhancement of experimental metastatic ability by tumor necrosis factor-alpha alone or in combination with interferon-gamma. Clin Exp Metast 8, 215–224 (1990). https://doi.org/10.1007/BF00117794
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00117794